Drug Trial Radar · NCT06947941
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Last checked: Nov 19, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
325
Planned (sponsor's estimate)
Start
Mar 25, 2026
Primary completion
Feb 21, 2028
Study completion Mar 20, 2028
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Apr 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.
Conditions
- Alzheimer Disease
- Psychosis
Interventions
KarXTDrug
Specified dose on specified days
KarX-ECDrug
Specified dose on specified days
KarXT + KarX-EC Arm Matching PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) ScoreTime frame: Up to approximately Week 14
Locations
22 sites in 5 countries. Site status is shown where the registry gives one.
Gilbert Neurology Partners/CCT Research
Gilbert, Arizona · Recruiting
Inland Psychiatric Medical Group.
Chino, California · Recruiting
Local Institution - 0001
Naples, Florida · Withdrawn
Local Institution - 1401
Naples, Florida · Not yet recruiting
Local Institution - 0029
Cleveland, Ohio · Not yet recruiting
Insight Clinical Trials LLC - Independence
Independence, Ohio · Recruiting
Local Institution - 0020
Macquarie Park, New South Wales, Australia · Not yet recruiting
Local Institution - 0052
Nedlands, Western Australia, Australia · Not yet recruiting
Local Institution - 0054
Toronto, Ontario, Canada · Not yet recruiting
Local Institution - 0027
Whitby, Ontario, Canada · Not yet recruiting
Local Institution - 0025
Montreal, Quebec, Canada · Not yet recruiting
Local Institution - 0035
Nankoku-shi, Japan · Not yet recruiting
Local Institution - 0034
Osaka, Japan · Not yet recruiting
Local Institution - 0040
Suita, Osaka, Japan · Not yet recruiting
Local Institution - 0018
Crowborough, United Kingdom · Withdrawn
Local Institution - 0024
London, United Kingdom · Not yet recruiting
Local Institution - 0004
Motherwell, United Kingdom · Not yet recruiting
Local Institution - 0005
Exeter, Devon, United Kingdom · Not yet recruiting
Local Institution - 0023
London, England, United Kingdom · Not yet recruiting
Local Institution - 0015
Oxford, Oxfordshire, United Kingdom · Withdrawn
Local Institution - 0009
Chertsey, Surrey, United Kingdom · Not yet recruiting
Local Institution - 0017
Sheffield, Yorkshire and the Humber, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.